| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/11/2001 | US6329197 DNA encoding galanin GALR3 receptors and uses thereof |
| 12/11/2001 | US6329194 Quantitative analysis |
| 12/11/2001 | US6329193 Taxol production by a microbe |
| 12/11/2001 | US6329180 Genetic analysis using peptide tagged in-vitro synthesized proteins |
| 12/11/2001 | US6329179 Extracting circulating rna from blood or plasma and utilizing nucleic acid amplification to screen for the presence of cancer or pre-cancer tissue; diagnosing cancer |
| 12/11/2001 | US6329166 Detection of first generational environmental sourced microbes in an environmentally-derived sample |
| 12/11/2001 | US6329165 Adding flourogenic dye directly into industrial water system, to react with planktonic or sessile microorganisms, measuring the fluorogenic dye signal and the reacted fluorogenic dye signal, determine ratio and monitor changes |
| 12/11/2001 | US6329164 Method for using a cell activity assay apparatus |
| 12/11/2001 | US6329162 Providing sample with glycine n-methyltransferase (gmt) and with an excess of s-adenosyl methionine (sam) and of glycine; providing a control which contains no folate with gmt and excess sam and glycine; comparing concentration of product |
| 12/11/2001 | US6329161 A flexible analyte sensor that is adapted for external positioning to an animal and for connection to a device for measuring an electrical signal generated by the sensor; for measuring glucose concentration in diabetes |
| 12/11/2001 | US6329160 A construct with nucleic acid molecule encoding a reporter molecule, a second molecule encoding an enzyme that produces a substrate for the reporter molecule; both being controlled by separate inducible promoter; for environmental monitoring |
| 12/11/2001 | US6329159 An antibody or antigen binding fragment which binds mammalian chemokine receptor and inhibits the binding of ligand to the receptor; therapy and diagnosis of inflammatory disease associated with mucosal tissues |
| 12/11/2001 | US6329158 Obtaining a fluid sample and combine with a nucleic acid dye and fluorescent antibodies that recognizes an antigen that is expressed by different cells to form a labeled solution; pass through a flow cytometer and measure fluorescence intensity |
| 12/11/2001 | US6329156 Method for screening inhibitors of the toxicity of Bacillus anthracis |
| 12/11/2001 | US6329154 Histamine measuring apparatus and a histamine measuring method |
| 12/11/2001 | US6329152 Permeabilizing cells in the presence of many different oligonucleotide probes with lengths of 15 to 30 nucleotides; the probes being labeled having melting point greater than 60 degrees celsius and hybridizes in the open reading frame |
| 12/11/2001 | US6329151 High density sampling of differentially expressed prokaryotic mRNA |
| 12/11/2001 | US6329150 Amplifying target circles by rolling circle replication of circular nucleic acids; detect amplified sequences using combinatorial multicolor coding probes for quantitative detection of multiple different amplified target circles |
| 12/11/2001 | US6329149 Reverse-root-canal method for extracting aDNA |
| 12/11/2001 | US6329147 Methods for detection of a triplet repeat block and a functional mismatch binding protein in a biological fluid sample |
| 12/11/2001 | US6329146 Mass spectrometric methods for biomolecular screening |
| 12/11/2001 | US6329145 Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligand |
| 12/11/2001 | US6329144 Probe for analysis of target nucleic acids |
| 12/11/2001 | US6329143 Providing a substrate having surface bearing multiple copies of a protective group removable on exposure to an electric field or electric current; applying electric field or current to substrate; exposing to protected monomer, repeating |
| 12/11/2001 | US6329142 Assay of nucleic acid by fluorescence polarization technique and detection of verotoxin-producing microorganisms |
| 12/11/2001 | US6329140 Screening clones on a support that is a high-density nucleic acid array by analyzing hybridization of a target nucleic acid with differently sequenced polynucleotide probes using various stringency conditions |
| 12/11/2001 | US6329138 Method for detection of the antibiotic resistance spectrum of mycobacterium species |
| 12/11/2001 | US6329137 Intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses |
| 12/11/2001 | US6328973 Method of raising neutralizing antibodies against HIV |
| 12/11/2001 | US6328971 MAGE-1 derived nona peptides, and compositions thereof |
| 12/11/2001 | CA2205057C Device and method for dna amplification and assay |
| 12/11/2001 | CA2177048C Ascorbate resistant detection of hydrogen peroxide |
| 12/11/2001 | CA2162286C Method of determining the amount of cholesterol in a high-density lipoprotein |
| 12/11/2001 | CA2162132C Hepatitis b virus mutants, reagents and methods for detection |
| 12/11/2001 | CA2136094C Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent |
| 12/11/2001 | CA2090614C 5' to 3' exonuclease mutations of thermostable dna polymerases |
| 12/11/2001 | CA2053284C Method for determination of glucose in whole blood and cuvette and photometer for carrying out said method |
| 12/09/2001 | CA2349959A1 Multiple coagulation test system and method of using a multiple coagulation test system |
| 12/09/2001 | CA2309379A1 Viral variants and uses therefor |
| 12/08/2001 | CA2345979A1 Probes and methods for detection of nucleic acids |
| 12/06/2001 | WO2001092891A2 Regulating lipid levels via the zmax1 or hbm gene |
| 12/06/2001 | WO2001092889A1 Low-enriched 13c-labelled urea composition for urea breath test |
| 12/06/2001 | WO2001092887A1 No wash bead assay, kit and procedure |
| 12/06/2001 | WO2001092877A2 Method of identifying and/or isolating stem cells |
| 12/06/2001 | WO2001092876A2 Method for identifying compounds for modulating the activity of a tumour suppressor protein |
| 12/06/2001 | WO2001092872A2 Methods for using mass spectrometry to identify and classify filamentous fungi, yeasts, molds and pollen |
| 12/06/2001 | WO2001092583A1 Determination of nucleotide sequence variations through limited primer extension |
| 12/06/2001 | WO2001092582A1 Haplotypes of the ube3a gene |
| 12/06/2001 | WO2001092581A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | WO2001092580A2 Lyophilizable and enhanced compacted nucleic acids |
| 12/06/2001 | WO2001092579A2 Methods for detecting target nucleic acids using coupled ligation and amplification |
| 12/06/2001 | WO2001092578A2 Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
| 12/06/2001 | WO2001092577A1 Extracellular drug-oligonucleotides chimeric molecules |
| 12/06/2001 | WO2001092576A1 Methods of screening for parkinson's disease |
| 12/06/2001 | WO2001092575A1 Multiplex amplification and analysis of selected str loci |
| 12/06/2001 | WO2001092574A2 Method for testing the inhibiting activity of a compound on an enzyme or for testing the resistance of an enzyme against inhibiting activity of a compound |
| 12/06/2001 | WO2001092573A1 Diagnosis kit for mycobacterium species identification and drug-resistance detection and manufacturing method thereof |
| 12/06/2001 | WO2001092571A1 Notch 4 and schizophrenia |
| 12/06/2001 | WO2001092570A2 Method to screen for improved meat characteristics in pigs |
| 12/06/2001 | WO2001092569A2 Formulation for polymerase chain reaction and vessel containing same |
| 12/06/2001 | WO2001092568A2 Method for producing dna-arrays |
| 12/06/2001 | WO2001092567A2 Novel target genes for diseases of the heart |
| 12/06/2001 | WO2001092565A2 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 12/06/2001 | WO2001092564A1 A method for determining the likelihood that a test polynucleotide sequence differs from a driver polynucleotide |
| 12/06/2001 | WO2001092563A2 Method for detecting a detectable product |
| 12/06/2001 | WO2001092562A2 Inhibiting retroviral integration by targeting the atm pathway |
| 12/06/2001 | WO2001092561A2 Method of screening for negative cross resistance |
| 12/06/2001 | WO2001092560A2 Assay for kinases and phosphatases |
| 12/06/2001 | WO2001092559A2 Screening system for antibiotics |
| 12/06/2001 | WO2001092558A2 End sequence profiling |
| 12/06/2001 | WO2001092552A2 Method for the purification of alphavirus replicon particles |
| 12/06/2001 | WO2001092551A2 Duplexed parvovirus vectors |
| 12/06/2001 | WO2001092549A2 Method and composition for targeting an adenoviral vector |
| 12/06/2001 | WO2001092530A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide |
| 12/06/2001 | WO2001092528A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |
| 12/06/2001 | WO2001092526A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | WO2001092525A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 12/06/2001 | WO2001092524A2 Myosin-like gene expressed in human heart and muscle |
| 12/06/2001 | WO2001092520A1 Modified chemokine receptor ccr-3 and assay |
| 12/06/2001 | WO2001092513A1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi |
| 12/06/2001 | WO2001092511A2 Purification of a triple heli formation with an immobilized oligonucleotide |
| 12/06/2001 | WO2001092510A1 Apparatus and method for separating and purifying polynucleotides |
| 12/06/2001 | WO2001092496A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | WO2001092492A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | WO2001092491A2 Mammalian protein phosphatases identified by in-silico analysis |
| 12/06/2001 | WO2001092490A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 12/06/2001 | WO2001092488A2 Regulation of human plc delta-1 |
| 12/06/2001 | WO2001092479A2 Method to determine the differentiation potential of a target cell |
| 12/06/2001 | WO2001092477A2 Three-dimensional skin model |
| 12/06/2001 | WO2001092474A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | WO2001092473A2 Method for cultivating a cartilage replacement and a biomatrix produced according to this method |
| 12/06/2001 | WO2001092463A2 Method of rna cleavage |
| 12/06/2001 | WO2001092338A1 Diagnosis of endometrial precancers |
| 12/06/2001 | WO2001092337A2 Soluble ctla4 mutant molecules and uses thereof |
| 12/06/2001 | WO2001092331A2 Compositions and methods for the treatment of immune related diseases |
| 12/06/2001 | WO2001092312A1 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 12/06/2001 | WO2001092308A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | WO2001092304A2 Transporters and ion channels |
| 12/06/2001 | WO2001092303A2 Human ion channels |